Clinical Trials Browser

Phase 2 × Unknown × Magnetic Resonance Spectroscopy × Clear all

NCT03226249 2023-06-02

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Phase 2 Unknown

30 enrolled 10 charts

Hodgkin Disease

NCT00324467 2021-07-22

LYTPET

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT00005084 2013-12-18

Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma

Phase 2 Unknown

Astrocytoma, Central Nervous System Neoplasms

NCT00083083 2011-03-01

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01260480 2010-12-17

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Phase 2 Unknown

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

NCT00805636 2010-05-12

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Phase 2 Unknown

Brain Neoplasms